Literature DB >> 6933159

Adjuvant treatment of ovarian carcinoma with tranexamic acid.

B Astedt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6933159      PMCID： PMC1347111     

Source DB:  PubMed          Journal:  J Clin Pathol Suppl (R Coll Pathol)        ISSN： 0144-0330


× No keyword cloud information.
  10 in total

1.  On the use of fibrinolysin inhibitors in plasma clot tissue culture.

Authors:  B INGEMANSON-NORDQVIST; B KALLEN
Journal:  Exp Cell Res       Date:  1960-10       Impact factor: 3.905

2.  The Application of Soybean Inhibitor in Tissue Cultivation.

Authors:  A Fischer
Journal:  Science       Date:  1949-06-17       Impact factor: 47.728

3.  Purification of urokinase by affinity chromatography.

Authors:  L Holmberg; B Bladh; B Astedt
Journal:  Biochim Biophys Acta       Date:  1976-08-12

4.  Treatment of advanced breast cancer with chemotherapeutics and inhibition of coagulation and fibrinolysis.

Authors:  B Astedt; W Mattsson; C Tropé
Journal:  Acta Med Scand       Date:  1977

5.  Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

Authors:  J K Christman; G Acs
Journal:  Biochim Biophys Acta       Date:  1974-03-27

6.  Arrest of growth of ovarian tumor by tranexamic acid.

Authors:  B Astedt; I Glifberg; W Mattsson; C Tropé
Journal:  JAMA       Date:  1977-07-11       Impact factor: 56.272

7.  Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.

Authors:  B Astedt; L Holmberg
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

8.  Release of fibrinolytic activators from human ovarian tumours in organ culture.

Authors:  L Svanberg; B Astedt
Journal:  Ann Chir Gynaecol       Date:  1976

9.  Antineoplastic-drug effect evaluated with a new X-ray stereophotographic measurement of the tumour volume.

Authors:  C Tropé; G Selvik; S Kullander; W Mattsson; A Mühlow; B Astedt
Journal:  Ann Chir Gynaecol       Date:  1978

10.  Properties of plasminogen activators formed by neoplastic human cell cultures.

Authors:  D B Rifkin; J N Loeb; G Moore; E Reich
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307
  10 in total
  1 in total

Review 1.  Clinical trials with anticoagulant and antiplatelet therapies.

Authors:  L R Zacharski; K R Meehan; S M Algarra; F A Calvo
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.